YHO-13351
YHO-13351 is an acrylonitrile-based ABCG2 inhibitor that sensitizes cancer stem-like side population cells to irinotecan. GSK1702934A is a research tool for studying diabetes, including investigations into TRPC channel function in pancreatic beta-cells in vitro.
Product Specifications
CAS Number
1346753-00-1
Product Name Alternative
YHO 13351, YHO13351, YHO-13351, ABCG2
Field of Research
Pharmacology & Drug Discovery
Purity
97.88% (May vary between batches)
Solubility
DMSO:160 mg/mL (275.99 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (8.62 mM)
Smiles
S (C) (=O) (=O) O.C (=C (\C#N) /C1=CC (OC) =C (OC) C=C1) \C=2SC (=CC2) N3CCC (OC (CN (CC) CC) =O) CC3
Molecular Formula
C27H37N3O7S2
Molecular Weight
579.73
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog